[Recent trends in therapy of chronic myeloproliferative disorders].
Fuse
I
I
D000477:Alkylating Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D007372:Interferons / Q000627:therapeutic use; D010885:Pipobroman / Q000627:therapeutic use; D011379:Prognosis; D013920:Thrombocythemia, Essential / Q000097:blood / Q000175:diagnosis / Q000628:therapy*
D000477:Alkylating Agents; D010885:Pipobroman; D007372:Interferons; D001241:Aspirin; D006918:Hydroxyurea